ICUA and Clínica CEMTRO have initiated their participation in the international multicenter clinical trial on the new device iTIND for the treatment of BPH and Marion's disease (primary sclerosis of the bladder neck).
The advantage of this device that is implanted in the prostatic urethra and is removed five days later is that it reshapes the anatomy of the bladder neck allowing for a much more comfortable micturition for patients without affecting ejaculation or sexual function.
We have carried out the first cases for the study and the recruitment is still open, so if you suffer from BPH contact us to see if you are a candidate to participate in this study.
The advantage of this device that is implanted in the prostatic urethra and is removed five days later is that it reshapes the anatomy of the bladder neck allowing for a much more comfortable micturition for patients without affecting ejaculation or sexual function.
We have carried out the first cases for the study and the recruitment is still open, so if you suffer from BPH contact us to see if you are a candidate to participate in this study.
Posts
No comments:
Post a Comment